From Wikipedia, the free encyclopedia
English medical scientist and immunologist
Sir Mark Jeremy Walport
FRS
FRCP
FRCPath
FMedSci
FRSE (born 25 January 1953
[3] ) is an English
medical scientist and was the
Government Chief Scientific Adviser in the United Kingdom from 2013 to 2017
[5]
[6]
[7]
[8]
[9]
[10]
[11]
[12] and Chief Executive of
UK Research and Innovation (UKRI) from 2017
[13] to 2020.
[14] In 2023 he became the Foreign Secretary of
The Royal Society (jointly with
Alison Noble ).
[15]
Education
Walport is the son of a
general practitioner and was born in London. He was educated at
St Paul's School, London ,
[3] studied medicine at
Clare College, Cambridge , and completed his clinical training at
Hammersmith ,
Guy's and
Brompton Hospitals in London.
[16]
[17] He was awarded a PhD for research into
complement receptors under the supervision of
Peter Lachmann in 1986 at the
University of Cambridge .
[18]
Career and research
Previously Walport was Director of the
Wellcome Trust from 2003 to 2013.
[4] Before this, he was Professor of Medicine (from 1991) and Head of the Division of Medicine (from 1997) at
Imperial College London ,
[16] where he led a research team that focused on the immunology and genetics of
rheumatic diseases .
[19]
[20]
[21]
[22]
[23]
[24]
[25]
[26]
Walport was the eleventh
Government Chief Scientific Adviser from 2013 to 2017, succeeding Sir
John Beddington .
It was announced in February 2017 that Mark Walport is now Chief Executive of
UK Research and Innovation (UKRI) .
[13]
Honours and awards
Walport was
knighted in the
2009 New Year Honours list for services to medical research. He was elected an Honorary
Fellow of the Royal Society of Edinburgh (FRSE) in 2017
[27] and a
Fellow of the Royal Society (FRS) in 2011.
[1]
[16] His nomination for the Royal Society reads:
Mark Walport has an overwhelming case for election both for his earlier scientific work on the immunology of
systemic LE and the role of complement and of defective
apoptosis in its
pathogenesis ; and, as a general candidate, for his achievements as head of medicine at the Hammersmith Campus of Imperial College and since 2003 as Director of the Wellcome Trust. In the latter role he has provided national and international leadership at the highest level on biomedical research and policy issues and is widely recognised as a world leader in the promotion of biomedical science.
[1]
References
^
a
b
c Anon (2011).
"Sir Mark Walport" .
Royal Society . Retrieved 5 July 2012 . One or more of the preceding sentences incorporates text from the royalsociety.org website where: “All text published under the heading 'Biography' on Fellow profile pages is available under
Creative Commons Attribution 4.0 International License .” --
Royal Society Terms, conditions and policies at the
Wayback Machine (archived 2016-11-11)
^ Reed, Tanya (11 July 2003).
"Wellcome to a new beginning" . Reporter: The newspaper of Imperial College London . No. 131.
^
a
b
c
d
e
f Anon (2015).
"Walport, Sir Mark (Jeremy)" .
Who's Who (online
Oxford University Press ed.). A & C Black.
doi :
10.1093/ww/9780199540884.013.U38753 . (Subscription or
UK public library membership required.)
^
a
b Vogel, Gretchen (2003).
"United Kingdom: Mark Walport to Take Reins at Wellcome Trust" . Science . 299 (5608): 803a–.
doi :
10.1126/science.299.5608.803a .
PMID
12574591 .
S2CID
70581694 .
^
a
b Callaway, Ewen (2012).
"Britain names next chief science adviser: Immunologist Mark Walport, head of one of the world's largest biomedical charities, will take on role in 2013" . Nature . 487 (7405): 20.
doi :
10.1038/487020a .
PMID
22763530 .
^ Mayor, S. (2012). "Mark Walport will be next UK government chief scientific adviser, cabinet office announces". BMJ . 345 : e4621.
doi :
10.1136/bmj.e4621 .
PMID
22767620 .
S2CID
11529948 .
^ Kain, K. H. (2010).
"Funding scientific discovery: An interview with Sir Mark Walport" . Disease Models & Mechanisms . 3 (5–6): 265–267.
doi :
10.1242/dmm.005710 .
PMID
20427555 .
^ Anon (2012).
"Good advice: The UK government's latest appointment offers hope for British science" . Nature . 487 (7405): 5–6.
doi :
10.1038/487005b .
PMID
22763508 .
^ Gibney, Elizabeth (29 June 2012).
"New chief scientific adviser announced" .
Times Higher Education .
^
Mark Walport's publications indexed by the
Scopus bibliographic database. (subscription required)
^
Sir Mark Walport in conversation with David Cleevely, Centre for Science and Policy (CSaP) University of Cambridge on
YouTube
^ Boulton, G.; Rawlins, M.; Vallance, P.; Walport, M. (2011). "Science as a public enterprise: The case for open data". The Lancet . 377 (9778): 1633–1635.
doi :
10.1016/S0140-6736(11)60647-8 .
PMID
21571134 .
S2CID
3048048 .
^
a
b
"Sir Mark Walport will lead UK Research and Innovation" . www.gov.uk (Press release). 2 February 2017. Retrieved 4 July 2017 .
^
"Dominic Cummings' science obsession: based on fact or fiction?" . Times Higher Education (THE) . 16 October 2019. Retrieved 25 November 2019 .
^
"Council" . The Royal Society . Retrieved 4 July 2023 .
^
a
b
c
"Dr Sir Mark Walport" .
Debrett's . Retrieved 14 February 2012 .
^ Morris, K. (2003). "Mark Walport".
The Lancet . 362 (9382): 498–499.
doi :
10.1016/S0140-6736(03)14090-1 .
PMID
12927451 .
S2CID
10861093 .
^ Walport, Mark Jeremy (1986).
The biology of complement receptors (PhD thesis). University of Cambridge.
OCLC
59761908 .
EThOS
uk.bl.ethos.383309 .
^
"Mark Walport, PhD, MB. BChir., Member, Scientific Board" .
Grand Challenges in Global Health . Archived from
the original on 27 September 2013. Retrieved 14 February 2012 .
^
Walport, M. ; Foulkes, I.; Weissberg, P.; Morgan, D.; Nebhrajani, S. (2012).
"Medical research: No catch to UK charity funding" . Nature . 482 (7385): 308.
Bibcode :
2012Natur.482..308W .
doi :
10.1038/482308a .
PMID
22337042 .
^ Collins, P. Y.; Patel, V.; Joestl, S. S.; March, D.; Insel, T. R.; Daar, A. S.; Scientific Advisory Board the Executive Committee of the Grand Challenges on Global Mental Health; Bordin, I. A.; Anderson, E. J.; Dhansay, M.; Phillips, C.; Shurin, R. I.; Walport, W.; Ewart, Y.; Savill, S. E.; Bordin, K.; Costello, S.; Durkin, S.; Fairburn, A.; Glass, A.; Hall, A.; Huang, M. M.; Hyman, V.; Jamison, B. J.; Kaaya, S.; Kapur, P. A.; Kleinman, D. J.; Ogunniyi, W.; Otero-Ojeda, M. A.; Poo, W.; Ravindranath, A. (2011).
"Grand challenges in global mental health" . Nature . 475 (7354): 27–30.
doi :
10.1038/475027a .
PMC
3173804 .
PMID
21734685 .
^ Yamada, T.; Dautry, A.;
Walport, M. (2008).
"Ready for avian flu?" . Nature . 454 (7201): 162.
Bibcode :
2008Natur.454..162Y .
doi :
10.1038/454162a .
PMID
18615064 .
S2CID
205039550 .
^ Pickering, M. C.; Warren, J.; Rose, K. L.; Carlucci, F.; Wang, Y.;
Walport, M. J. ; Cook, H. T.; Botto, M. (2006).
"Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice" . Proceedings of the National Academy of Sciences . 103 (25): 9649–9654.
Bibcode :
2006PNAS..103.9649P .
doi :
10.1073/pnas.0601094103 .
PMC
1476693 .
PMID
16769899 .
^ Brown, J. S.; Hussell, T.; Gilliland, S. M.; Holden, D. W.; Paton, J. C.; Ehrenstein, M. R.;
Walport, M. J. ; Botto, M. (2002).
"The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice" . Proceedings of the National Academy of Sciences . 99 (26): 16969–16974.
Bibcode :
2002PNAS...9916969B .
doi :
10.1073/pnas.012669199 .
PMC
139253 .
PMID
12477926 .
^ Botto, M.; Fong, K. Y.; So, A. K.; Barlow, R.; Routier, R.; Morley, B. J.;
Walport, M. J. (1992).
"Homozygous hereditary C3 deficiency due to a partial gene deletion" . Proceedings of the National Academy of Sciences of the United States of America . 89 (11): 4957–4961.
Bibcode :
1992PNAS...89.4957B .
doi :
10.1073/pnas.89.11.4957 .
PMC
49207 .
PMID
1350678 .
^ Taylor, P. R.; Carugati, A.; Fadok, V. A.; Cook, H. T.; Andrews, M.; Carroll, M. C.;
Savill, J. S. ; Henson, P. M.; Botto, M.; Walport, M. J. (2000).
"A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells in Vivo" . Journal of Experimental Medicine . 192 (3): 359–366.
doi :
10.1084/jem.192.3.359 .
PMC
2193213 .
PMID
10934224 .
^
"RSE Welcomes 60 New Fellows" (Press release).
Royal Society of Edinburgh . 15 February 2017. Retrieved 28 March 2017 .
This article incorporates
text available under the
CC BY 4.0 license.
Centres and institutes
Projects and facilities Board of governors Executive leadership team
Jeremy Farrar
Chris Bird
Stephen Caddick
Simon Chaplin
Alyson Fox
Peter Pereira Gray
Mark Henderson
Chonnettia Jones
Tim Livett
Nick Moakes
Kathy Poole
Jim Smith
James Thomas
Ed Whiting
Former directors Other key people Awards and fellowships
International National Academics Other